Matrix metalloproteinase-2 promoter variability in psoriasis

Archives of Dermatological Research

Volumn 301, Issue 6, 2009, Pages 467-473

  Vasku, Vladimir ^a   Bienertova Vasku, Julie ^b   Slonková, Veronika ^a   Kaňková, Kateřina ^b   Vasku, Anna ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Allergy; Diabetes; Family history; Gene polymorphism; MMP 2; Predisposition; Psoriasis

Indexed keywords

ADENOSINE; CYTOSINE; GELATINASE A; GUANINE; THIOURACIL;

ADULT; ALLELE; ALLERGY; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHROMOSOME 16Q; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; TONSILLECTOMY; TONSILLITIS;

ADULT; AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 16; CZECH REPUBLIC; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERSENSITIVITY; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PEDIGREE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PSORIASIS;

EID: 68149129715     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0947-5     Document Type: Article

References (35)

1. M Beránek P Kolar S Tschoplova 2008 Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy Mol Vis 14 1114 1121 (Pubitemid 351850566)
2. P Borgiani L Vallo MR D'Apice 2002 Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population Eur J Dermatol 12 540 542 (Pubitemid 35440789)
3. M Chen ZQ Chen PG Cui 2008 The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance Br J Dermatol 158 987 993 10.1111/j.1365-2133.2008.08505.x
4. M Chen PG Cui X Yao 2007 The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24 674 676
5. E Christophers 2007 Comorbidities in psoriasis Clin Dermatol 25 529 534 10.1016/j.clindermatol.2007.08.006
6. P Cordiali-Fei E Trento G D'Agosto 2007 Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions Ann NY Acad Sci 1110 578 589 10.1196/annals.1423.062
7. E Deniaud J Baguet AL Mathieu 2006 Overexpression of Sp1 transcription factor induces apoptosis Oncogene 25 7096 7105 10.1038/sj.onc.1209696
8. G Derosa I Ferrari A D'Angelo 2008 Matrix metalloproteinase-2 and -9 levels in obese patients Endothelium 15 219 224 10.1080/10623320802228815
9. M Fatar M Stroick M Steffens 2008 Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes Cerebrovasc Dis 26 113 119 10.1159/000139657
10. R Fleischmajer K Kuroda R Hazan 2000 Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2 J Invest Dermatol 115 771 777 10.1046/j.1523-1747.2000.00138.x
11. O Fuchs 2006 EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases Cas Lek Cesk 145 619 624 (Pubitemid 44638032)
12. B Głowińska-Olszewska M Urban B Florys 2006 Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 12 179 183 (Pubitemid 44520954)
13. YP Han TL Tuan H Wu 2001 TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP J Cell Sci 114 131 139 (Pubitemid 32118063)
14. S Harendza DH Lovett U Panzer 2003 Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness J Biol Chem 278 20490 20499 10.1074/jbc.M211536200
15. LI Holla A Fassmann A Vasku 2005 Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis J Periodontol 76 1056 1060 10.1902/jop.2005.76.7.1056
16. International Psoriasis Genetics Consortium 2003 The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs Am J Hum Genet 73 430 437 10.1086/377159
17. L Jakobsson L Claesson-Welsh 2008 Vascular basement membrane components in angiogenesis-an act of balance ScientificWorldJournal 8 1246 1249 10.1100/tsw.2008.155
18. AM Langers CF Sier LJ Hawinkels 2008 MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not Br J Cancer 98 1820 1823 10.1038/sj.bjc.6604380
19. EB Mark M Jonsson J Asp 2006 Expression of genes involved in the regulation of p16 in psoriatic involved skin Arch Dermatol Res 297 459 467 10.1007/s00403-006-0649-1
20. A Mastroianni E Minutilli A Mussi 2005 Cytokine profiles during infliximab monotherapy in psoriatic arthritis Br J Dermatol 153 531 536 10.1111/j.1365-2133.2005.06648.x
21. V Miksztowicz ML Muzzio M Royer 2008 Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome Metabolism 57 1493 1496 10.1016/j.metabol.2008.06.001
22. RP Nair T Henseler S Jenisch 1997 Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan Hum Mol Genet 6 1349 1356 10.1093/hmg/6.8.1349
23. RP Nair P Stuart T Henseler 2000 Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C Am J Hum Genet 66 1833 1844 10.1086/302932
24. RP Nair P Stuart Y Ogura 2001 Lack of association between NOD2 3020insC frameshift mutation and psoriasis J Invest Dermatol 117 1671 1672 10.1046/j.0022-202x.2001.01620.x
25. P Nemec M Goldbergová T Swobodnik 2006 Polymorphism of gene promoter region for MMP-2 in rheumatoid arthritis Vnitr Lek 52 348 354
26. SJ Price DR Greaves H Watkins 2001 Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation J Biol Chem 276 7549 7558 10.1074/jbc.M010242200
27. P Rahman S Bartlett F Siannis 2003 CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis Am J Hum Genet 73 677 681 10.1086/378076
28. JA Segre C Bauer E Fuchs 1999 Klf4 is a transcription factor required for establishing the barrier function of the skin Nat Genet 22 356 360 10.1038/11926
29. S Shahabi ZM Hassan NH Jazani 2006 Sympathetic nervous system plays an important role in the relationship between immune mediated diseases Med Hypotheses 67 900 903 10.1016/j.mehy.2006.03.039
30. O Simonetti G Lucarini G Goteri 2006 VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study Int J Immunopathol Pharmacol 19 751 760 (Pubitemid 46145039)
31. S Sipetić H Vlajinac N Kocev 2002 Family history and risk of type 1 diabetes mellitus Acta Diabetol 39 111 10.1007/s005920200028
32. A Vasku M Goldbergová L Izakovicová Hollá 2004 A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease Matrix Biol 22 585 591 10.1016/j.matbio.2003.10.004
33. V Vasku A Vasku S Tschöplová 2002 Genotype association of C(-735)T polymorphism in matrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis Dermatology 204 262 265 10.1159/000063355
34. CH Wang HC Chang WC Hung 2006 p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription J Cell Physiol 208 246 252 10.1002/jcp.20660
35. M Xue CJ Jackson 2008 Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes J Invest Dermatol 128 2676 2685 10.1038/jid.2008.136